[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-368932-en":59,"doc-seo-368932-105":98},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":72,"language_code":73,"site_id":74,"html_lang":73,"table_of_contents":75,"faqs":76,"seo_title":77,"seo_description":66,"update_tm":78,"read_time":79,"preview_page_count":19,"preview_urls":80},368932,687212321768,"Guten tag","https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","KIAA1199 - A Novel Regulator of Chemoresistance in Human Cancer Cells - Review","KIAA1199 (CEMIP or HYBID), an archived gene in the Human Unidentified Gene-Encoded (HUGE) database, is linked to tumor progression and metastasis across many cancer types. Its overexpression correlates with poor prognosis and clinical chemoresistance, and it may function as a biomarker for diagnosis and outcome, particularly through maintenance of cancer stem cell properties. The review consolidates existing evidence on how KIAA1199 regulates chemoresistance, prognosis, and cancer stem cell biology.","KIAA1199: A Novel Regulator of  \nChemoresistance in Human Cancer Cells  \nCancer Control Volume 32: 1-9 © The Author(s) 2025 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/10732748251379926](DOI: 10.1177/10732748251379926)  \n[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)  \nHong-Quan Duong, PhD 1 􀀁, Thi-Ngoc-Lan Dao, ThS2, Van-Lang Ngo, ThS3, Thi-Thu-Phuong Pham, ThS 1, Thi-Nguyet Dao, ThS4, and Van-Thu Le, ThS 1  \nAbstract  \nKIAA1199 (also known as CEMIP or HYBID), an archived gene listed in the Human Unidentiﬁed Gene-Encoded (HUGE) database, has been implicated in tumor progression and metastasis in a wide range of cancers, including breast, cervical, cholangiocarcinoma, pancreatic, colorectal, gastric, hepatocellular, lung, ovarian, prostate, papillary thyroid, and brain cancers. Overexpression of KIAA1199 is signiﬁcantly correlated with poor prognosis and metastasis and has been clinically associated with chemoresistance. In addition, KIAA1199 may serve as a novel biomarker for cancer diagnosis and prognosis, particularly due to its role in maintaining cancer stem cell properties. However, the molecular mechanisms by which KIAA1199 regulateschemoresistance, prognosis, and cancer stem cell development remain incompletely understood. Therefore, this review aims to summarize the clinical relevance of KIAA1199 as a novel regulator involved in chemoresistance, cancer prognosis, and cancer stem cell biology.  \nKeywords  \nKIAA1199, chemoresistance, prognosis, cancer drug resistance, cancer stem cells  \nReceived: May 14, 2025; revised: August 18, 2025; accepted: September 2, 2025.  \nIntroduction  \nKIAA1199 (CEMIP, HYBID), a 150 Kda protein encoded by a gene located on chromosome 15q25.1, is an archived gene listed in the Human Unidentiﬁed Gene-Encoded (HUGE) protein database.1 KIAA1199 was initially described in association with nonsyndromic hearing loss,2 as well as with cancer initiation and progression,3 osteoarthritis and rheumatoid arthritis,4 atherosclerosis,5 and idiopathic pulmonary ﬁbrosis.6 To date, the HUGE database includes more than 2400 entries, conventionally designated with the preﬁx“KIAA” followed by a four-digit number, beginning with KIAA0001 .7 KIAA1199 was ﬁrst investigated as a protein of unknown function in 1999, 1 and later identiﬁed as an inner ear–speciﬁc protein in 2003 .2 It localizes to the cytoplasm,8 particularly around the perinuclear region in the endoplasmic reticulum.9 Importantly, KIAA1199 detected in cell culture media is a secreted protein rather than a transmembrane protein.3  \nThe KIAA1199 protein consists of 136 amino acids and includes 3 domains and an N-terminal secretion signal sequence. These domains comprise 2 GG domains and 1 G8 domain. The GG domain, approximately 100 amino acids in length and composed of 7 β-strands and 2 α-helices, is involved in hyaluronic acid binding and/or degradation. This is supported by evidence showing that a single mutation in the ﬁrst GG domain impairs hyaluronidase activity.2,4 The  \n1 Laboratory Center, Hanoi University of Public Health, Vietnam 2Department of Microbiology and National TB Reference Laboratory, National Lung Hospital, Hanoi, Vietnam  \n3Faculty of Biomedical Sciences, Phenikaa University, Hanoi, Vietnam 4Pathology Department, Ducgiang General Hospital, Hanoi, Vietnam  \nCorresponding Author:  \nHong-Quan Duong, Laboratory Center, Hanoi University of Public Health, 1A Duc Thang, Dong Ngac, Hanoi 100000, Vietnam.  \nEmail: [dhq@huph.edu.vn](dhq@huph.edu.vn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without further permission provided the original w","cbCaiodLRuVa4xse","https://ap.wps.com/l/cbCaiodLRuVa4xse","pdf",774493,"English","en",105,"# Abstract\n# Introduction\n## Gene features and cellular localization\n## Protein domains and functional implications\n## Gene regulation mechanisms\n## Links to cancer progression and chemoresistance","[{\"question\":\"What is KIAA1199 and where is it listed?\",\"answer\":\"KIAA1199 (also called CEMIP or HYBID) is an archived gene in the Human Unidentified Gene-Encoded (HUGE) database. It is associated with tumor progression and metastasis across multiple cancers.\"},{\"question\":\"How does KIAA1199 relate to prognosis and chemoresistance?\",\"answer\":\"Overexpression of KIAA1199 is significantly associated with poor prognosis and metastasis. It is also clinically linked to chemoresistance in various cancers.\"},{\"question\":\"What mechanisms are proposed for how KIAA1199 is regulated?\",\"answer\":\"KIAA1199 expression is regulated by genetic and epigenetic mechanisms, including promoter binding by NF-KB and AP-1, DNA methylation of CpG islands, and histone modifications such as H3K4me3 and H3K27me3, as well as microRNAs and inflammatory cytokines.\"}]","KIAA1199 - A Novel Regulator of Chemoresistance in Human Cancer Cells - Review | PDF",1790179260,23,[81,85,89,94],{"page_no":8,"url":82,"width":83,"height":84},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f8125195f035d55bb800041af16632e.webp",983,1272,{"page_no":14,"url":86,"width":87,"height":88},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d06f2a996368b54db5376e00c8838db2.webp",982,1270,{"page_no":90,"url":91,"width":92,"height":93},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d214c830cb17543604daa07518d5059.webp",981,1269,{"page_no":19,"url":95,"width":96,"height":97},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90e4eb577c12271c22e32b806a5a628e.webp",980,1268,{"code":4,"msg":99,"data":100},"ok",{"site_id":74,"language":73,"slug":101,"title":65,"keywords":102,"description":66,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"kiaa1199-a-novel-regulator-of-chemoresistance-in-human-cancer-cells-review","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":9,"@type":111,"position":14},"https://docshare.wps.com/document/",{"item":115,"name":40,"@type":111,"position":90},"https://docshare.wps.com/document/research-report/",{"item":117,"name":65,"@type":111,"position":19},"https://docshare.wps.com/document/kiaa1199-a-novel-regulator-of-chemoresistance-in-human-cancer-cells-review/368932/",{"url":117,"name":65,"@type":119,"image":120,"author":125,"headline":65,"publisher":127,"fileFormat":130,"inLanguage":73,"description":66,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/kiaa1199-a-novel-regulator-of-chemoresistance-in-human-cancer-cells-review/368932.png","ImageObject",300,407,{"name":63,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":135,"interactionType":136,"userInteractionCount":34},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"What is KIAA1199 and where is it listed?","Question",{"text":145,"@type":146},"KIAA1199 (also called CEMIP or HYBID) is an archived gene in the Human Unidentified Gene-Encoded (HUGE) database. It is associated with tumor progression and metastasis across multiple cancers.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"How does KIAA1199 relate to prognosis and chemoresistance?",{"text":150,"@type":146},"Overexpression of KIAA1199 is significantly associated with poor prognosis and metastasis. It is also clinically linked to chemoresistance in various cancers.",{"name":152,"@type":143,"acceptedAnswer":153},"What mechanisms are proposed for how KIAA1199 is regulated?",{"text":154,"@type":146},"KIAA1199 expression is regulated by genetic and epigenetic mechanisms, including promoter binding by NF-KB and AP-1, DNA methylation of CpG islands, and histone modifications such as H3K4me3 and H3K27me3, as well as microRNAs and inflammatory cytokines.","https://schema.org",{"og:url":117,"og:type":157,"og:title":65,"og:site_name":128,"og:description":66},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":61,"site_id":74},1791341834]